Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MiddleBrook Pharmaceuticals, a developer of anti-infective drug products, has announced that the professional launch of Moxatag tablets, 775mg, will begin on March 16, 2009.
Subscribe to our email newsletter
The company has hired over half of its 270-person field force which will promote Moxatag, said to be the first and only FDA-approved once-daily amoxicillin, to health care professionals nationwide. Moxatag is approved for the treatment of adults and pediatric patients 12 years and older with tonsillitis or pharyngitis.
MiddleBrook has also announced that it completed its manufacturing validation of Moxatag, and in preparation for the Moxatag trade launch, Moxatag shipments to the company’s third-party logistics provider began in January 2009.
John Thievon, president and CEO of MiddleBrook, said: “All 30 of our district sales managers are now on board, and with over half of our sales force hired, we can say that MiddleBrook is well on its way to becoming a sales-driven organization.”